Summit Trail Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Buy |
+19,222
| New | +$15M | 0.26% | 50 |
|
|
2024
Q4 | – | Sell |
-7,549
| Closed | -$6.69M | – | 605 |
|
|
2024
Q3 | $6.69M | Buy |
7,549
+718
| +11% | +$636K | 0.17% | 62 |
|
|
2024
Q2 | $6.18M | Sell |
6,831
-777
| -10% | -$703K | 0.16% | 57 |
|
|
2024
Q1 | $5.92M | Buy |
7,608
+644
| +9% | +$501K | 0.16% | 55 |
|
|
2023
Q4 | $4.06M | Sell |
6,964
-87
| -1% | -$50.7K | 0.13% | 62 |
|
|
2023
Q3 | $3.79M | Buy |
7,051
+416
| +6% | +$223K | 0.14% | 60 |
|
|
2023
Q2 | $3.11M | Buy |
6,635
+3,531
| +114% | +$1.66M | 0.12% | 71 |
|
|
2023
Q1 | $1.07M | Buy |
3,104
+634
| +26% | +$218K | 0.04% | 121 |
|
|
2022
Q4 | $904K | Buy |
2,470
+196
| +9% | +$71.7K | 0.04% | 125 |
|
|
2022
Q3 | $735K | Buy |
2,274
+653
| +40% | +$211K | 0.04% | 131 |
|
|
2022
Q2 | $526K | Buy |
1,621
+627
| +63% | +$203K | 0.03% | 174 |
|
|
2022
Q1 | $285K | Buy |
994
+1
| +0.1% | +$287 | 0.02% | 257 |
|
|
2021
Q4 | $274K | Buy |
+993
| New | +$274K | 0.02% | 242 |
|
|
2018
Q2 | – | Sell |
-2,967
| Closed | -$237K | – | 574 |
|
|
2018
Q1 | $237K | Sell |
2,967
-336
| -10% | -$26.8K | 0.04% | 333 |
|
|
2017
Q4 | $279K | Buy |
+3,303
| New | +$279K | 0.04% | 338 |
|